RFK Jr. removes all 17 members of U.S. vaccine advisory panel
U.S. Health Secretary Robert F. Kennedy Jr. on Monday removed every member of a scientific committee that advises the Centers for Disease Control and Prevention on how to use vaccines and pledged to replace them with his own picks.
Major physicians and public health groups criticized the move to oust all 17 members of the Advisory Committee on Immunization Practices.
Kennedy, who was one of the nation's leading anti-vaccine activists before becoming the nation's top health official, has not said who he would appoint to the panel, but said it would convene in just two weeks in Atlanta.
Although it's typically not viewed as a partisan board, the Biden administration had installed the entire committee.
'Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028,' Kennedy wrote in a Wall Street Journal opinion piece. 'A clean sweep is needed to re-establish public confidence in vaccine science.'
Story continues below advertisement
Kennedy said the committee members had too many conflicts of interest. Committee members routinely disclose any possible conflicts at the start of public meetings.
Dr. Georges Benjamin, executive director of the American Public Health Association, called Kennedy's mass ouster 'a coup.'
'It's not how democracies work. It's not good for the health of the nation,' Benjamin told The Associated Press.
0:37
RFK announces COVID vaccine removal from immunization schedule for pregnant women and children
Benjamin said the move raises real concerns about whether future committee members will be viewed as impartial. He added that Kennedy is going against what he told lawmakers and the public, and the public health association plans to watch Kennedy 'like a hawk.'
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
'He is breaking a promise,' Benjamin said. 'He said he wasn't going to do this.'
Dr. Bruce A. Scott, president of the American Medical Association, called the committee a trusted source of science- and data-driven advice and said Kennedy's move, coupled with declining vaccination rates across the country, will help drive an increase in vaccine-preventable diseases.
Story continues below advertisement
'Today's action to remove the 17 sitting members of ACIP undermines that trust and upends a transparent process that has saved countless lives,' Scott said in a statement.
Republican Sen. Bill Cassidy of Louisiana, a doctor who had expressed reservations about Kennedy's nomination but voted to install him as the nation's health secretary nonetheless, said he had spoken with Kennedy moments after the announcement.
'Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion,' Cassidy said in a social media post. 'I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case.'
9:34
RFK Jr. and Elizabeth Warren get into heated debate over vaccine question at confirmation hearing
The committee had been in a state of flux since Kennedy took over. Its first meeting this year had been delayed when the U.S. Department of Health and Human Services abruptly postponed its February meeting.
Story continues below advertisement
During Kennedy's confirmation, Cassidy had expressed concerns about preserving the committee, saying he had sought assurances that Kennedy would keep the panel's current vaccine recommendations.
Kennedy did not stick to that. He recently took the unusual step of changing COVID-19 recommendations without first consulting the advisers.
The webpage that featured the committee's members was deleted Monday evening, shortly after Kennedy's announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Japan Forward
2 hours ago
- Japan Forward
AI Tool 'KIBIT': A Game Changer in New Drug Development
このページを 日本語 で読む The COVID-19 pandemic reminded the world of the importance of drug discovery. However, modern drug discoveries require massive financial investment. Meanwhile, the use of artificial intelligence for AI drug discovery is gaining attention as a way to control soaring pharmaceutical prices. And a Japanese-made AI tool named 'KIBIT' is about to open up a new stage in this field. President Donald Trump issued executive orders in April and May mandating the reduction of domestic drug prices in the United States. Accompanying White House fact sheets refer to the high cost Americans pay for prescriptions, which is 2.78 times higher than the OECD average. Prescription costs are also 3.47 times higher than in Japan. Trump sees these high costs to consumers as a serious issue. In Japan, a national drug pricing system sets medication prices, enabling access to affordable treatments due to governmental oversight. In contrast, US pharmaceutical companies can set prices freely. This often results in higher charges than in other countries. Following his May 12 executive order, Trump stated that his orders would cut prices by 59% to as much as 90% to align with the levels of other countries. This could potentially result in significant revenue losses for the pharmaceutical industry. In the case of Japan, major pharmaceutical companies such as Takeda Pharmaceutical Company Limited and Astellas Pharma Inc earn over 30% of their revenue from the US. According to his comments, the President could impose additional tariffs on foreign-manufactured drugs if prices are not reduced. In the search for new drugs and treatments (Screenshot, ©FRONTEO Inc) One major reason for rising drug prices is the increasing cost of research and development. The average R&D spending by Japanese pharmaceutical companies rose from ¥30.2 billion JPY ($298.7 million USD) in 1993 to 163.3 billion ($1.13 billion) in 2019 — a 5.4-fold increase over 26 years. US companies saw an even sharper rise, from $841 million (¥121.1 billion) to $7.449 billion (¥1.0725 trillion). That marked an 8.8-fold increase. Moreover, investing in R&D doesn't guarantee success. The probability of developing a successful drug in Japan dropped from 1 in 13,000 two decades ago to 1 in 23,000 recently. Despite the increasing costs, results are scarce. Consequently, the R&D-to-revenue ratio rose from about 10% in 1993 to around 18% in 2019 in both countries. Introducing KIBIT. (Screenshot ©FRONTEO Inc) AI is being eyed as a solution to reduce R&D costs by dramatically cutting time and expenses. Drug development involves four stages: Basic research & target identification Compound optimization Preclinical trials and Clinical trials. Many AI vendors are involved in drug discovery. In particular, they focus on reducing costs in the third (preclinical) and fourth (clinical) stages. However, most companies have yet to tackle the critical first stage — target identification. Introducing KIBIT. (Screenshot, ©FRONTEO Inc) The first enterprise to address this initial stage is the Japanese company FRONTEO. Utilizing its proprietary natural language processing AI engine KIBIT, the company analyzes vast medical and pharmaceutical literature to generate innovative drug ideas that researchers may not have considered. Human thinking is inherently biased. The more experienced a researcher is, the more difficult it becomes to identify novel molecular targets. Stated another way, the bias of experience often blocks new ideas. KIBIT, however, is free from such biases. It identifies new molecular targets that might be effective against specific diseases. To do so, it analyzes vast amounts of academic literature. It can even derive specific hypotheses. Furthermore, KIBIT can identify and suggest highly disease-relevant target molecules that are not explicitly mentioned in the literature. This significantly enhances drug discovery potential. How KIBIT works. (Screenshot, ©FRONTEO Inc) Only a few countries have the capacity to develop new drugs. In 2024, among newly approved pharmaceuticals in Japan, the US, and Europe, the US led with 143 products. Japan followed with just 12, roughly equal to the United Kingdom's 10. According to the statistics "Nationalities of companies creating the top 100 drugs in the world by sales (2022),": United States – 52 United Kingdom – 10 Switzerland – 9 Germany – 8 Denmark – 8 Japan – 7 Most countries, other than the US, struggle to produce blockbuster drugs. In this context, hopes are high for FRONTEO's KIBIT. If it can consistently generate innovative new drugs efficiently, it may help deliver affordable medicines to those in need, without Mr Trump's intervention. FRONTEO's AI drug discovery service, utilizing KIBIT, is already being adopted by several major pharmaceutical companies. Those leveraging KIBIT to create new drugs could become game changers in the industry. This article is contributed by FRONTEO Inc, a supporting member of JAPAN Forward. (Read the report in Japanese.) Author: FRONTEO Inc. このページを 日本語 で読む
Winnipeg Free Press
2 hours ago
- Winnipeg Free Press
Los Angeles imposes downtown curfew as protests against Trump's immigration crackdown continue
LOS ANGELES (AP) — Los Angeles leaders imposed a downtown curfew through Wednesday morning to deal with protests against President Donald Trump's immigration crackdown, while the governor accused him of drawing a 'military dragnet' across the nation's second-largest city with his escalating use of the National Guard. Democratic Gov. Gavin Newsom asked a court to put an emergency stop to the military helping federal immigration agents, with some guardsmen now standing in protection around agents as they carried out arrests. He said it would only heighten tensions and promote civil unrest. The judge chose not to rule immediately, giving the administration several days to continue those activities before a hearing Thursday. The change moves troops closer to engaging in law enforcement actions like deportations as Trump has promised as part of his administration's immigration crackdown. The Guard has the authority to temporarily detain people who attack officers but any arrests ultimately would be made by law enforcement. Trump has activated more than 4,000 National Guard members and 700 Marines over the objections of city and state leaders, though the Marines have not yet been spotted in Los Angeles and Guard troops have had limited engagement with protesters. They were originally deployed to protect federal buildings. As the curfew went into effect Tuesday night, a police helicopter flew over downtown federal buildings that have been the center of protests and ordered people to leave the area. Riot police on horses and foot surrounded a group of a few hundred that had gathered in the area, shouting: 'Move!' Most of the protesters scattered, with some regrouping and refusing orders to disperse. Officials said the curfew was necessary to stop vandalism and theft by agitators looking to cause trouble. Demonstrations have spread to other cities nationwide, including Dallas and Austin, Texas, Chicago and New York, where a thousand people rallied and multiple arrests were made. In Texas, where police in Austin used chemical irritants to disperse several hundred demonstrators Monday, Republican Gov. Greg Abbott's office said Texas National Guard troops were 'on standby' in areas where demonstrations are planned, Abbott spokesperson Andrew Mahaleris said Tuesday evening. Guard members were deployed to San Antonio, according to assistant police chief Jesse Salame. He said he did not know how many were sent or details on the deployment. LA mayor puts curfew in place Los Angeles Mayor Karen Bass declared a local emergency on the fifth day of protests and said the curfew will run from 8 p.m. Tuesday until 6 a.m. Wednesday. She said it was expected to last for several days. 'We reached a tipping point' after 23 businesses were looted, Bass said during a news conference Tuesday. The curfew covers a 1 square mile (2.5 square kilometer) section of downtown that includes the area where protests have occurred since Friday. The city of Los Angeles encompasses roughly 500 square miles (nearly 2,300 square kilometers). The curfew doesn't apply to residents who live in the designated area, people who are homeless, credentialed media or public safety and emergency officials, according to Los Angeles Police Chief Jim McDonnell. McDonnell said 'unlawful and dangerous behavior' had been escalating since Saturday. 'The curfew is a necessary measure to protect lives and safeguard property following several consecutive days of growing unrest throughout the city,' McDonnell said. Trump says he's open to using Insurrection Act Trump left open the possibility of invoking the Insurrection Act, which authorizes the president to deploy military forces inside the U.S. to suppress rebellion or domestic violence or to enforce the law in certain situations. It's one of the most extreme emergency powers available to a U.S. president. 'If there's an insurrection, I would certainly invoke it. We'll see,' he said from the Oval Office. Later the president called protesters 'animals' and 'a foreign enemy' in a speech at Fort Bragg ostensibly to recognize the 250th anniversary of the U.S. Army. Trump has described Los Angeles in dire terms that Bass and Newsom say are nowhere close to the truth. In a public address Tuesday evening, Newsom called Trump's actions the start of an 'assault' on democracy. 'California may be first, but it clearly will not end here. Other states are next,' he said. Newsom warned people against inciting violence, but urged them to stand up to the president's actions. 'What Donald Trump wants most is your fealty, your silence. To be complicit in this moment,' he said. 'Do not give it to him.' The protests began Friday after federal immigration raids arrested dozens of workers in Los Angeles. Protesters blocked a major freeway and set cars on fire over the weekend, and police responded with tear gas, rubber bullets and flash-bang grenades. The demonstrations have been mostly concentrated downtown in the city of 4 million. Thousands of people have peacefully rallied outside City Hall and hundreds more protested outside a federal complex that includes a detention center where some immigrants are being held following workplace raids. Despite the protests, immigration enforcement activity has continued throughout the county, with city leaders and community groups reporting ICE present at libraries, car washes and Home Depots. School graduations in Los Angeles have increased security over fears of ICE action and some have offered parents the option to watch on Zoom. McDonnell said that police had made 197 arrests on Tuesday, including 67 who were taken into custody for unlawfully occupying part of the 101 freeway. Several businesses were broken into Monday, though authorities didn't say if the looting was tied to the protests. The vast majority of arrests have been for failing to disperse, while a few others were for assault with a deadly weapon, looting, vandalism and attempted murder for tossing a Molotov cocktail. Seven police officers were reportedly injured, and at least two were taken to a hospital and released. Defense Secretary Pete Hegseth suggested Tuesday that the use of troops inside the U.S. will continue to expand. The Pentagon said deploying the National Guard and Marines costs $134 million. ___ Baldor and Copp reported from Washington. Associated Press writers Dorany Pineda and Christopher Weber in Los Angeles, Amy Taxin in Orange County, California, John Seewer in Toledo, Ohio, Jim Vertuno in Austin, Texas, Hallie Golden in Seattle, and Greg Bull in Seal Beach, California, contributed to this report.
Winnipeg Free Press
3 hours ago
- Winnipeg Free Press
A federal appeals court is set to hear arguments in Trump's bid to erase his hush money conviction
NEW YORK (AP) — President Donald Trump's quest to erase his criminal conviction heads to a federal appeals court Wednesday. It's one way he's trying to get last year's hush money verdict overturned. A three-judge panel is set to hear arguments in Trump's long-running fight to get the New York case moved from state court to federal court, where he could then try to have the verdict thrown out on presidential immunity grounds. The Republican is asking the 2nd U.S. Circuit Court of Appeals to intervene after a lower-court judge twice rejected the move. As part of the request, Trump wants the federal appeals court to seize control of the criminal case and then ultimately decide his appeal of the verdict, which is now pending in a state appellate court. The 2nd Circuit should 'determine once and for all that this unprecedented criminal prosecution of a former and current President of the United States belongs in federal court,' Trump's lawyers wrote in a court filing. The Manhattan district attorney's office, which prosecuted Trump's case, wants it to stay in state court. Trump's Justice Department — now partly run by his former criminal defense lawyers — backs his bid to move the case to federal court. If Trump loses, he could go to the U.S. Supreme Court. Trump was convicted in May 2024 of 34 felony counts of falsifying business records to conceal a hush money payment to porn actor Stormy Daniels, whose affair allegations threatened to upend his 2016 presidential campaign. Trump denies her claim and said he did nothing wrong. It was the only one of his four criminal cases to go to trial. Trump's lawyers first sought to move the case to federal court following his March 2023 indictment, arguing that federal officers including former presidents have the right to be tried in federal court for charges arising from 'conduct performed while in office.' Part of the criminal case involved checks he wrote while he was president. They tried again after his conviction, arguing that Trump's historic prosecution violated his constitutional rights and ran afoul of the Supreme Court's presidential immunity ruling, which was decided about a month after the hush money trial ended. The ruling reins in prosecutions of ex-presidents for official acts and restricts prosecutors in pointing to official acts as evidence that a president's unofficial actions were illegal. U.S. District Judge Alvin Hellerstein denied both requests, ruling in part that Trump's conviction involved his personal life, not his work as president. In a four-page ruling, Hellerstein wrote that nothing about the high court's ruling affected his prior conclusion that hush money payments at issue in Trump's case 'were private, unofficial acts, outside the bounds of executive authority.' Trump's lawyers argue that prosecutors rushed to trial instead of waiting for the Supreme Court's presidential immunity decision, and that prosecutors erred by showing jurors evidence that should not have been allowed under the ruling, such as former White House staffers describing how Trump reacted to news coverage of the hush money deal and tweets he sent while president in 2018. Trump's former criminal defense lawyer Todd Blanche is now the deputy U.S. attorney general, the Justice Department's second-in-command. Another of his lawyers, Emil Bove, has a high-ranking Justice Department position. The trial judge, Juan M. Merchan, rejected Trump's requests to throw out the conviction on presidential immunity grounds and sentenced him on Jan. 10 to an unconditional discharge, leaving his conviction intact but sparing him any punishment. Appearing by video at his sentencing, Trump called the case a 'political witch hunt,' 'a weaponization of government' and 'an embarrassment to New York.'
